These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Acute effect of 3-(4-acetamido)-butyrril-lorazepam (DDS2700) on brain function assessed by PET at rest and during attentive tasks. Moresco RM; Tettamanti M; Gobbo C; Del Sole A; Ravasi L; Messa C; Paulesu E; Lucignani G; Perani D; Fazio F Nucl Med Commun; 2001 Apr; 22(4):399-404. PubMed ID: 11338050 [TBL] [Abstract][Full Text] [Related]
7. Decreased cerebral response to inhibitory neurotransmission in alcoholics. Volkow ND; Wang GJ; Hitzemann R; Fowler JS; Wolf AP; Pappas N; Biegon A; Dewey SL Am J Psychiatry; 1993 Mar; 150(3):417-22. PubMed ID: 8382010 [TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study. Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Gatley SJ; Dewey SS; Pappas N Am J Psychiatry; 1998 Feb; 155(2):200-6. PubMed ID: 9464198 [TBL] [Abstract][Full Text] [Related]
9. Depression of thalamic metabolism by lorazepam is associated with sleepiness. Volkow ND; Wang GJ; Hitzemann R; Fowler JS; Pappas N; Lowrimore P; Burr G; Pascani K; Overall J; Wolf AP Neuropsychopharmacology; 1995 Apr; 12(2):123-32. PubMed ID: 7779240 [TBL] [Abstract][Full Text] [Related]
10. The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans. Schreckenberger M; Lange-Asschenfeldt C; Lochmann M; Mann K; Siessmeier T; Buchholz HG; Bartenstein P; Gründer G Neuroimage; 2004 Jun; 22(2):637-44. PubMed ID: 15193592 [TBL] [Abstract][Full Text] [Related]
11. Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. Volkow ND; Wang GJ; Begleiter H; Hitzemann R; Pappas N; Burr G; Pascani K; Wong C; Fowler JS; Wolf AP Alcohol Clin Exp Res; 1995 Apr; 19(2):510-6. PubMed ID: 7625590 [TBL] [Abstract][Full Text] [Related]
12. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes. Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013 [TBL] [Abstract][Full Text] [Related]
14. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury. Kato T; Nakayama N; Yasokawa Y; Okumura A; Shinoda J; Iwama T J Neurotrauma; 2007 Jun; 24(6):919-26. PubMed ID: 17600509 [TBL] [Abstract][Full Text] [Related]
15. Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam. Hege SG; Ellinwood EH; Wilson WH; Helligers CA; Graham SM Psychopharmacology (Berl); 1997 May; 131(2):101-7. PubMed ID: 9201796 [TBL] [Abstract][Full Text] [Related]
16. The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. O'Neill WM; Hanks GW; Simpson P; Fallon MT; Jenkins E; Wesnes K Pain; 2000 Mar; 85(1-2):209-15. PubMed ID: 10692620 [TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Buchsbaum MS; Wu J; Haier R; Hazlett E; Ball R; Katz M; Sokolski K; Lagunas-Solar M; Langer D Life Sci; 1987 Jun; 40(25):2393-400. PubMed ID: 2884547 [TBL] [Abstract][Full Text] [Related]
18. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve. Yoshizawa H; Gazes Y; Stern Y; Miyata Y; Uchiyama S Psychiatry Res; 2014 Jan; 221(1):78-85. PubMed ID: 24262800 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126 [TBL] [Abstract][Full Text] [Related]
20. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]